NIH-funded research R01 grant

FoRtitude: An eHealth program to help breast cancer survivors manage fear of recurrence

Official title: Randomized controlled trial of FoRtitude: Targeted eHealth intervention to reduce fear of recurrence among breast cancer survivors in community oncology settings

Funded at Univ of North Carolina Chapel Hill · NIH-11128786 · Data updated 2026-11-12

This program offers breast cancer survivors an online tool to help them cope with the worry that their cancer might come back.

More Breast Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startAugust 1, 2024
Project endJuly 31, 2029
Funding year2025
Award (this year)$657,618
NIH project number5R01CA282682-02
Project IDNIH-11128786 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this program are breast cancer survivors who experience moderate to severe fear that their cancer might return.

Less likely to help

Patients who do not experience fear of recurrence or are not breast cancer survivors may not find this program beneficial.

What this research studies

Many breast cancer survivors experience a deep worry about their cancer returning, even years after treatment. This program, called FoRtitude, is an online tool designed to teach coping strategies based on cognitive behavioral therapy (CBT). It aims to make these helpful strategies more accessible to survivors who might face challenges like finding providers or managing costs. The program also includes culturally sensitive content and support through telephone coaching to help more people benefit.

Why it matters

Potential benefit: If successful, this program could provide an accessible and effective way for breast cancer survivors to significantly reduce their fear of recurrence and improve their quality of life.

How similar studies have gone: A previous version of this program, FoRtitude 1.0, showed a significant reduction in fear of recurrence among breast cancer survivors who participated.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Wagner, Lynne I. — Univ of North Carolina Chapel Hill
  • Study coordinator: Wagner, Lynne I.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.